Literature DB >> 19082598

Genetic variation in the interleukin-10 gene promoter in Polish patients with systemic lupus erythematosus.

Adam Sobkowiak1, Margarita Lianeri, Mariusz Wudarski, Jan K Łacki, Paweł P Jagodziński.   

Abstract

Identification of susceptibility genes in systemic lupus erythematosus (SLE) has recently become a topic of interest. The IL-10 promoter contains three single base-pair substitutions at -627C > A, -854C > T and -1117G > A. These single base-pair substitutions produce three different haplotypes, GCC, ACC and ATA, which affect IL-10 expression. We examined the distribution of -627C > A, -854C > T and -1117G > A IL-10 promoter polymorphisms in patients with SLE (n = 103, women only) and matched controls (n = 300). Despite the higher prevalence of the GCC/GCC, GCC/ATA and ATA/ATA genotypes in SLE patients than in controls, we observed that only GCC/GCC genotype frequency distribution was significant between these groups. We observed that women with the GCC/GCC genotype displayed an approximately twofold increased risk of SLE OR = 2.245 (95% CI = 1.354-3.721, P = 0.0022). We did not find any associations between various genotypes of IL-10 promoter haplotypes and clinical manifestations or autoantibody production in patients with SLE. Our observations indicate that the GCC/GCC promoter genotype may contribute to SLE incidence in Polish patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082598     DOI: 10.1007/s00296-008-0776-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

1.  Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus.

Authors:  E Crawley; P Woo; D A Isenberg
Journal:  Arthritis Rheum       Date:  1999-09

2.  Haplotype associated with low interleukin-10 production in patients with severe asthma.

Authors:  S Lim; E Crawley; P Woo; P J Barnes
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies.

Authors:  Piotr C Piotrowski; Sergiusz Duriagin; Paweł P Jagodzinski
Journal:  Clin Rheumatol       Date:  2005-07-13       Impact factor: 2.980

5.  Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.

Authors:  E Crawley; R Kay; J Sillibourne; P Patel; I Hutchinson; P Woo
Journal:  Arthritis Rheum       Date:  1999-06

6.  Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.

Authors:  C J Edwards-Smith; J R Jonsson; D M Purdie; A Bansal; C Shorthouse; E E Powell
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

7.  Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.

Authors:  M Lazarus; A H Hajeer; D Turner; P Sinnott; J Worthington; W E Ollier; I V Hutchinson
Journal:  J Rheumatol       Date:  1997-12       Impact factor: 4.666

Review 8.  Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10).

Authors:  L J Rosenwasser; L Borish
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

9.  Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus.

Authors:  C C Mok; J S Lanchbury; D W Chan; C S Lau
Journal:  Arthritis Rheum       Date:  1998-06

10.  Angiotensin-converting enzyme gene polymorphism in Kuwaiti patients with systemic lupus erythematosus.

Authors:  A M Al-Awadhi; M Z Haider; P N Sharma; E A Hasan; F Botaiban; A Al-Herz; I Nahar; H Al-Enezi; K Al-Saeid
Journal:  Clin Exp Rheumatol       Date:  2007 May-Jun       Impact factor: 4.473

View more
  6 in total

1.  Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Ashley J Wilhelm; Nekeithia S Wade; Curtis L Gabriel; John J Kastelein; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

Review 2.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

Review 3.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Authors:  Hui Peng; Wei Wang; Mo Zhou; Rui Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2013-05-25       Impact factor: 2.980

Review 4.  Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview.

Authors:  Hwa Chia Chai; Maude Elvira Phipps; Kek Heng Chua
Journal:  Clin Dev Immunol       Date:  2011-09-20

5.  Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations.

Authors:  De Azevêdo Silva J; Addobbati C; Sandrin-Garcia P; Crovella S
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

6.  IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.

Authors:  Ping Liu; Jianwen Song; Hui Su; Linli Li; Ning Lu; Rongli Yang; Zhenhui Peng
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.